InvestorsHub Logo
icon url

NASDAQ2020

06/16/15 10:49 PM

#157297 RE: WeeZuhl #157283

That Prediction seems reasonable.
Let the ADT Games begin!
icon url

NASDAQ2020

06/16/15 11:01 PM

#157298 RE: WeeZuhl #157283

1. Oxy-IR ELI-200
2. Oxy 12 HR ELI-201
3. Oxy 24 HR ELI-216
4. Hydrocodone 24 HR ELI-???
5. Oxy/pain co/drug. ELI-202

icon url

IB_

06/17/15 9:52 AM

#157335 RE: WeeZuhl #157283

2018 ?? Elite was suppose to be in the "real money" in 2015-2016 !! 3-5 years from 2011 before the real money ??? So Elite may get bought out in 2018 but we were told the Real Money will be made before Dec.31 2016 !!!


IB_ ;)
icon url

no2koolaid

06/17/15 1:40 PM

#157389 RE: WeeZuhl #157283

Always enjoy your posts. However, being true to my nom de plume, I have to disagree with your assessment on a buy out in 2018. My response to such a date is - WHY BOTHER? If Elite were to arrive at that year and they have hit the Nasdaq, filed and had approved multiple ADFs, increased the number of generics and their sales (however, small), and even reduced R&D costs associated with fewer trials, I would seriously argue they would have a firm capable of achieving the heights suggested by those using the seemingly wildly enthusiastic comparisons to Pharmacyclics and Jazz. Realistically, when there is the potential for their tech platform that would enable multiple filings, the math becomes compelling for continuing on their current path . How much so? That answer is complex...